» Articles » PMID: 31491709

Influenza Virus-specific CD4+ and CD8+ T Cell-mediated Immunity Induced by Infection and Vaccination

Overview
Journal J Clin Virol
Specialty Microbiology
Date 2019 Sep 7
PMID 31491709
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

Influenza A and B virus infections are a major cause of respiratory disease in humans and are responsible for substantial morbidity and mortality worldwide. Vaccination against influenza mainly aims at the induction of virus neutralizing serum antibodies, which are an important correlate of protection provided that the antibodies match the strains causing the outbreaks antigenically. In addition, virus-specific T cells are known to contribute to protective immunity to influenza virus infections by limiting duration and severity of the disease. As the majority of virus-specific T cells recognize epitopes located in relatively conserved proteins, like the Nucleoprotein and Matrix 1 protein, they display a high degree of cross-reactivity with a wide range of influenza viruses, including newly emerging viruses of alternative subtypes. Advancing our understanding of influenza virus-specific T cell responses and their role in protective immunity against influenza will aid the rational design of novel vaccines that could induce robust, broad and long-lasting immune responses. Here, we discuss the contribution of influenza virus-specific CD4+ and CD8+ T cells to protective immunity against influenza infection and the requirements and strategies for their induction by natural infection or vaccination, especially in children.

Citing Articles

Endocrine and molecular regulation of seasonal avian immune function.

Sur S, Tiwari J, Malik S, Stevenson T Philos Trans R Soc Lond B Biol Sci. 2025; 380(1918):20230507.

PMID: 39842486 PMC: 11753886. DOI: 10.1098/rstb.2023.0507.


Similar humoral responses but distinct CD4 T cell transcriptomic profiles in older adults elicited by MF59 adjuvanted and high dose influenza vaccines.

Quach H, Haralambieva I, Goergen K, Grill D, Chen J, Ovsyannikova I Sci Rep. 2024; 14(1):24420.

PMID: 39424894 PMC: 11489691. DOI: 10.1038/s41598-024-75250-2.


Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccines.

Hauguel T, Sharma A, Mastrocola E, Lowry S, Maddur M, Hu C NPJ Vaccines. 2024; 9(1):183.

PMID: 39375384 PMC: 11488230. DOI: 10.1038/s41541-024-00980-3.


A Recombinant Mosaic HAs Influenza Vaccine Elicits Broad-Spectrum Immune Response and Protection of Influenza a Viruses.

Liu X, Luo C, Yang Z, Zhao T, Yuan L, Xie Q Vaccines (Basel). 2024; 12(9).

PMID: 39340038 PMC: 11435869. DOI: 10.3390/vaccines12091008.


Headless hemagglutinin-containing influenza viral particles direct immune responses toward more conserved epitopes.

Hamele C, Luo Z, Leonard R, Spurrier M, Burke K, Webb S J Virol. 2024; 98(10):e0116624.

PMID: 39324791 PMC: 11495035. DOI: 10.1128/jvi.01166-24.